Continue reading Stack3d

One Of One combines PeptiStrong and DL185 for its versatile non-hormonal muscle builder

One Of One Peptide Builder

Peptide Builder is the muscle builder in the family of Floyd Mayweather’s all-new supplement company, One Of One, and it is actually rather intriguing. While most sports nutrition brands would allocate that section of benefits and effects to something like a testosterone booster, Peptide Builder takes a different sort of route. The product features a non-hormonal formula, bringing together two of the most increasingly popular ingredients currently in the world of muscle builders.

One Of One’s Peptide Builder is true to its name and includes the AI-discovered peptide PeptiStrong fava bean protein isolate at a full dose of 2.4g, and making up the other half of the supplement is DL185 dileucine, offering a 159% increase in muscle protein synthesis and 60% over standard leucine. The muscle-building duo brings a whole host of benefits to the table, supporting strength, performance, recovery, muscle growth, and reduced muscle atrophy for a quality competitor.

One Of One Peptide Builder Label

PeptiStrong is one of the biggest new entries in the category of muscle-building and has come a long way over the last couple of years, finding its way into all sorts of innovations in several small to big-name brands. Here in One Of One’s Peptide Builder, you get PeptiStrong and DL185 teaming up for a non-hormonal product that can be used alongside most other muscle builders due to the simplicity and versatility of the formula.

Peptide Builder is one of the most expensive supplements from Floyd Mayweather’s new brand, One Of One, sitting up above the $60 mark, although that top-end cost has been a common theme with PeptiStrong and even DL185 products. The proven muscle building product is coming to market tomorrow alongside all of One Of One’s other innovations from pre-workout to creatine and protein powder, with a retail price of $64.99 for a bottle of 30 servings to last a typical month.

COMMENTS